<DOC>
	<DOCNO>NCT00162552</DOCNO>
	<brief_summary>In patient cirrhosis liver failure , pro-inflammatory cytokine ( TNF alpha ) might responsible severe complication death . Thus , prevention cytokine production prevent complication mortality . The aim study study 2 month survival rate patient severe cirrhosis ( Child-Pugh C ) pentoxifylline - inhibitor cytokine production . The 6 month mortality , proportion transplant patient , occurrence complication ( bacterial infection , renal failure , hepatic encephalopathy gastrointestinal bleeding ) , plasma cytokine level fibrotest - marker fibrosis - also study . This multicenter double blind randomize trial placebo . All adult patient severe cirrhosis might randomize write consent . Patients severe carcinoma , intolerance contraindication pentoxifylline include . Patients receive either pentoxifylline placebo 3 time day 6 month . Three hundred forty two patient necessary decrease mortality rate 50 % 2 month beta risk 10 % alpha risk 5 % . Patients see every month .</brief_summary>
	<brief_title>Clinical Trial Pentoxifylline Patient With Cirrhosis</brief_title>
	<detailed_description>The aim study study 2 month survival rate patient severe cirrhosis ( Child-Pugh C ) pentoxifylline - inhibitor cytokine production . The 6 month mortality , proportion transplant patient , occurrence complication ( bacterial infection , renal failure , hepatic encephalopathy gastrointestinal bleeding ) , plasma cytokine level fibrotest - marker fibrosis - also study . This multicenter double blind randomize trial placebo . All adult patient severe cirrhosis might randomize write consent . Patients severe carcinoma , intolerance contraindication pentoxifylline include . Patients receive either pentoxifylline placebo 3 time day 6 month . Three hundred forty two patient necessary decrease mortality rate 50 % 2 month beta risk 10 % alpha risk 5 % . Patients see every month .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>adult patient 18 year child pugh C cirrhosis pregnant woman Patient receive anticoagulant Patient treat arterial hypertension Patient severe coronaropathy Patient hyper sensibility pentoxifylline Patient hospitalize less 24 hour Patient admit treatment hepatocellularcarcinoma COLLANGIO carcinoma Patient HIV Patient transplant Patient treat immuno suppressor Patient already receive pentoxifylline 3 month inclusion Patient followup consider impossible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>multicenter-randomized-trial</keyword>
	<keyword>pentoxifyllinE</keyword>
	<keyword>placebo</keyword>
	<keyword>cirrhosis</keyword>
	<keyword>liver failure</keyword>
	<keyword>cytokine</keyword>
</DOC>